Medical News

RSS

Shire's ADHD treatment data to be presented at the Honolulu psychiatric meeting

Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.

30 Oct 2009

Studies demonstrate that investigational cancer vaccines show encouraging immune response rates

Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies.

30 Oct 2009

Smartphones for diabetic patients

Cellular phones - once a luxury used strictly for talking - have taken on many new roles in recent years. Now researchers at Saint Louis University and Old Dominion University in Virginia say smartphones can be used to help elderly diabetics manage their health and learn more about their condition.

30 Oct 2009

Leading gynecologist recommends flu shots for pregnant women

Randy A. Fink, MD says pregnant women ought to be shot – with a flu vaccination needle. “A flu shot offers double protection to both mother and baby,” says Dr. Fink, a Miami board certified specialist who was recently named one of “America's Top Obstetrician/Gynecologists” by the Consumer Research Council.

30 Oct 2009

USANA’s Active Calcium Chewable supplement improves bone health in young girls

USANA Health Sciences, Inc. announced today that a third-party clinical study led by Dr. David Greene at Australian Catholic University (ACU National) found that use of USANA’s Active Calcium™ Chewable supplement improves bone health in young girls.

30 Oct 2009

Mobile phones on the verge of becoming powerful tools

Computer scientists at the University of Washington have used Android, the open-source mobile operating system championed by Google, to turn a cell phone into a versatile data-collection device. Organizations that want a fully customizable way to, say, snap pictures of a deforested area, add the location coordinates and instantly submit that information to a global environmental database now have a flexible and free way to do it.

30 Oct 2009

Second-quarter fiscal 2010 results announced by Quality Systems

Quality Systems, Inc. today announced the results of operations for its fiscal 2010 second quarter ended September 30, 2009. The Company posted record net revenues of $71.7 million in the second quarter, an increase of 22% from the $59.0 million generated during the same quarter of the prior year.

30 Oct 2009

University of Iowa receives a $26.4M gift commitment from the Pappajohns

University of Iowa President Sally Mason announced today a $26.4 million gift commitment from longtime UI benefactors John and Mary Pappajohn of Des Moines -- the largest single gift commitment ever for the UI from individual Iowa donors -- and said it will provide the university's new interdisciplinary Institute for Biomedical Discovery with "the catalyst it needs to reach its full potential."

30 Oct 2009

Antioxidants may hold the key in preventing severe flu-related lung damage

As the nation copes with a shortage of vaccines for H1N1 influenza, a team of Alabama researchers have raised hopes that they have found an Achilles' heel for all strains of the flu-antioxidants. In an article appearing in the November 2009 print issue of the FASEB Journal (http://www.fasebj.org) they show that antioxidants-the same substances found in plant-based foods-might hold the key in preventing the flu virus from wreaking havoc on our lungs.

30 Oct 2009

New state-of-the-art biotechnology center opened on the West Coast

As part of its strategy to discover and develop more biotechnology medicines, Eli Lilly and Company today officially opened a new state-of-the-art biotechnology center on the West Coast.

30 Oct 2009

NeuroVigil and Roche collaborate to speed up drug development for CNS disorders

Today, leading California Neurotechnology company NeuroVigil and Swiss Pharma giant Roche announced an agreement regarding a major innovation in collecting and analyzing data from clinical trials.

30 Oct 2009

La Jolla Institute dedicates new Elam Discovery Wall and Type 1 Diabetes Center

The La Jolla Institute for Allergy & Immunology, an international leader in immunology research and San Diego's only research institute focused solely on immune-mediated diseases, today will dedicate its new Elam Discovery Wall and Type 1 Diabetes Center, which will focus on research into novel immunological-focused approaches to type 1 diabetes.

30 Oct 2009

Any cuts to the prescription drug program will affect senior citizens, says Network/Alliance

The Older Canadians Network / Alliance of Seniors (Network/Alliance) is warning the Ontario government that any cuts to the prescription drug program would disproportionately affect the province's senior citizens.

30 Oct 2009

UCSF scientists receive grants to advance stem cell based strategies for diabetes and brain tumors

Two teams of UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their stem cell based strategies for treating diabetes and brain tumors.

30 Oct 2009

The Netherlands Antilles Public Health Inspectorate issues importation approval for TNS' ImmuSANO and GlucoSANO

Total Nutraceutical Solutions, Inc., announced today that it has received approval for importation of ImmuSANO™ and GlucoSANO™ from the Inspectorate of Public Health, Bureau of Pharmaceutical Affairs in Curacao, The Netherlands Antilles.

30 Oct 2009

New study reviews science behind the efficacy of biofield therapies on pain management

Biofield therapies, which claim to use subtle energy to stimulate the body's healing process, are promising complementary interventions for reducing the intensity of pain in a number of conditions, reducing anxiety for hospitalized patients and reducing agitated behaviors in dementia, over and above what standard treatments can achieve.

30 Oct 2009

Echo Therapeutics enhances its needle-free Symphony tCGM biosensor

Echo Therapeutics, Inc., a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, announced today that it has made significant advances to the development of its needle-free Symphony tCGM biosensor.

30 Oct 2009

Americans United for Life CEO's statement on the new House health care bill

"Just as Americans United for Life had expected, the new House health care bill unveiled this morning includes the Capps Amendment language added during the Energy and Commerce Committee mark-up. This bill will explicitly allow federal funding of abortion through the public option and permits federal subsidies to go to private insurance plans that cover abortion. The bill also ensures that at least one health insurance plan must cover abortion in every area of the country."

30 Oct 2009

Pre-dialysis recipients with high kidney function do not benefit from kidney transplants

Pre-dialysis transplant recipients with a high level of kidney function don't benefit from their transplant more than pre-dialysis recipients with low level kidney function, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.

30 Oct 2009

Hard to Treat Diseases negotiating possible merger with EU based stem cell research company

Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.

30 Oct 2009